Clopidogrel eluting electrospun polyurethane/polyethylene glycol thromboresistant,hemocompatible nanofibrous scaffolds

Abstract

Biomaterials used as blood-contacting material must be hemocompatible and exhibit lower thrombotic potential while maintaining hemostasis and angiogenesis. With the aim of developing thromboresistant, hemocompatible nanofibrous scaffolds, polyurethane/polyethylene glycol scaffolds incorporated with 1, 5, and 10 wt% Clopidogrel were fabricated and evaluated for their physiochemical properties, biocompatibility, hemocompatibility, and antithrombotic potential. The results of physicochemical characterization revealed the fabrication of nanometer-sized scaffolds with smooth surfaces. The incorporation of both polyethylene glycol and Clopidogrel to polyurethane enhanced the hydrophilicity and water uptake potential of polyurethane/polyethylene glycol/Clopidogrel scaffolds. The dynamic mechanical analysis revealed the enhancement in mechanical strength of the polyurethane/polyethylene glycol scaffolds on incorporation of Clopidogrel. The polyurethane/polyethylene glycol/Clopidogrel scaffolds showed a tri-phasic drug release pattern. The results of hemocompatibility assessment demonstrated the excellent blood compatibility of the polyurethane/polyethylene glycol/Clopidogrel scaffolds, with the developed scaffolds exhibiting lower hemolysis, increased albumin and plasma protein adsorption while reduction in fibrinogen adsorption. Further, the platelet adhesion was highly suppressed and significant increase in coagulation period was observed for Clopidogrel incorporated scaffolds. The results of cell adhesion and cell viability substantiate the biocompatibility of the developed nanofibrous scaffolds with the HUVEC cell viability on polyurethane/polyethylene glycol, polyurethane/polyethylene glycol/Clopidogrel-1, 5, and 10% at day 7 found to be 12.35, 13.36, 14.85, and 4.18% higher as compared to polyurethane scaffolds, and the NIH/3T3 cell viability found to be 35.27, 70.82, 36.60, and 7.95% higher as compared to polyurethane scaffolds, respectively. Altogether the results of the study advocate the incorporation of Clopidogrel to the polyurethane/polyethylene glycol blend in order to fabricate scaffolds with appropriate antithrombotic property, hemocompatibility, and cell proliferation capacity and thus, might be successfully used as antithrombotic material for biomedical application.

Keywords

Hemocompatible electrospinning platelet adhesion cardiovascular coagulation

Get full access to this article

View all access options for this article.

References

Henry

JJ.

Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 2011; 15: 451–475.

Merkle

Martin

Hutchinson

et al . Hemocompatibility of poly (vinyl alcohol)–gelatin core–shell electrospun nanofibers: a scaffold for modulating platelet deposition and activation. ACS Appl Mater Interfaces 2015; 7: 8302–8312.

Rubenstein

Venkitachalam

Zamfir

et al . In vitro biocompatibility of sheath–core cellulose-acetate-based electrospun scaffolds towards endothelial cells and platelets. J Biomater Sci Polym Ed 2010; 21: 1713–1736.

Lam

JC.

Biomaterial applications in cardiovascular tissue repair and regeneration. Expert Rev Cardiovasc Ther 2012; 10: 1039–1049.

Firkowska‐Boden

et al . Controlling protein adsorption through nanostructured polymeric surfaces. Adv Healthcare Mater 2018; 7: 1700995.

Hasan

Memic

Annabi

et al . Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomater 2014; 10: 11–25.

Bhardwaj

Kundu

SC.

Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv 2010; 28: 325–347.

Greiner

Wendorff

JH.

Electrospinning: a fascinating method for the preparation of ultrathin fibers. Angew Chem Int Ed 2007; 46: 5670–5703.

Wang

Feng

Fang

et al . Co-electrospun blends of PU and PEG as potential biocompatible scaffolds for small-diameter vascular tissue engineering. Mater Sci Eng C 2012; 32: 2306–2315.

10.

Teo

Mishra

Park

et al . Polymeric biomaterials for medical implants and devices. ACS Biomater Sci Eng 2016; 2: 454–472.

11.

Del Gaudio

Ercolani

Galloni

et al . Aspirin-loaded electrospun poly (ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention. J Mater Sci: Mater Med 2013; 24: 523–532.

12.

Pektok

Nottelet

Tille

et al . Degradation and healing characteristics of small-diameter poly (ε-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118: 2563–2570.

13.

Maya

Weatherspoon

Young

et al . Increased risk of infection associated with polyurethane dialysis grafts. Semin Dial 2007; 20: 616–620.

14.

Jaganathan

SK.

Hydrochloric acid treated polyurethanes for temporary blood contacting biomaterials applications. Biomed Res 2017; 28: 5107–5113.

15.

Davalos

Akassoglou

Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012; 34: 43–62.

16.

Karahaliloglu

Electrospun PU-PEG and PU-PC hybrid scaffolds for vascular tissue engineering. Fibers Polym 2017; 18: 2135–2145.

17.

Bauer

Siedlecki

CA.

Proteins, platelets, and blood coagulation at biomaterial interfaces. Colloids Surf B Biointerfaces 2014; 124: 49–68.

18.

Park

Surface modification using silanated poly(ethylene glycol)s. Biomaterials 2000; 21: 605–616.

19.

Kim

Park

et al . Immobilization of poly (ethylene glycol) or its sulfonate onto polymer surfaces by ozone oxidation. Biomaterials 2001; 22: 2115–2123.

20.

Park

Shim

Dewanjee

et al . In vitro and in vivo studies of PEO-grafted blood-contacting cardiovascular prostheses. J Biomater Sci Polym Ed 2000; 11: 1121–1134.

21.

Nojiri

Okano

Jacobs

et al . Blood compatibility of PEO grafted polyurethane and HEMA/styrene block copolymer surfaces. J Biomed Mater Res 1990; 24: 1151–1171.

22.

Field

Benavente

OR.

Current status of antiplatelet agents to prevent stroke. Curr Neurol Neurosci Rep 2011; 11: 6–14.

23.

Gurbel

Tantry

US.

The role of clopidogrel in cardiovascular diseases. Pol Arch Med Wewn 2007; 117: 207.

24.

Bertrand

Rupprecht

Urban

et al . Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 2000; 102: 624–629.

25.

Gao

Feng

et al . Grafting of phosphorylcholine functional groups on polycarbonate urethane surface for resisting platelet adhesion. Mater Sci Eng C 2013; 33: 2871–2878.

26.

Giram

Shitole

Nande

et al . Fast dissolving moxifloxacin hydrochloride antibiotic drug from electrospun Eudragit L-100 nonwoven nanofibrous mats. Mater Sci Eng C 2018; 92: 526–539.

27.

Raut

Khandwekar

Sharma

Polyurethane–polyvinylpyrrolidone iodine blends as potential urological biomaterials. J Mater Sci 2018; 53: 11176–11193.

28.

Gao

et al . Rationally designed dual functional block copolymers for bottlebrush-like coatings: in vitro and in vivo antimicrobial, antibiofilm, and antifouling properties. Acta Biomater 2017; 51: 112–124.

29.

Khandwekar

Patil

Shouche

et al . Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility. J Biomater Appl 2011; 26: 227–252.

30.

Jaganathan

Mani

Ismail

et al . Manufacturing and characterization of novel electrospun composite comprising polyurethane and mustard oil scaffold with enhanced blood compatibility. Polymers 2017; 9: 163.

31.

Milleret

Hefti

Hall

et al . Influence of the fiber diameter and surface roughness of electrospun vascular grafts on blood activation. Acta Biomater 2012; 8: 4349–4356.

32.

Fatisson J, Mansouri S, Merhi Y, et al. Determination of surface-induced platelet activation by applying time-dependency dissipation factor versus frequency using quartz crystal microbalance with dissipation. J R Soc Interface 2011; 8: 988–997.

33.

Song

Ravensbergen

Alabanza

et al . Distinct adsorption configurations and self-assembly characteristics of fibrinogen on chemically uniform and alternating surfaces including block copolymer nanodomains. ACS Nano 2014; 8: 5257–5269.

34.

Kumar

Parajuli

Gupta

et al . Elucidation of protein adsorption behavior on polymeric surfaces: toward high-density, high-payload protein templates. Langmuir 2008; 24: 2688–2694.

35.

Absolom

Zingg

Neumann

AW.

Protein adsorption to polymer particles: role of surface properties. J Biomed Mater Res 1987; 21: 161–2.

36.

Krishnan

Cha

Liu

et al . Interfacial energetics of blood plasma and serum adsorption to a hydrophobic self-assembled monolayer surface. Biomaterials 2006; 27: 3187–3194.

37.

Rao

Lakshmi

KR.

Design, development and evaluation of clopidogrel bisulfate floating tablets. Int J Pharma Investig 2014; 4: 19.

38.

Zhang

Easteal

AJ.

Thermoanalytical, spectroscopic, and morphological study of poly(ethylene glycol)/poly(2‐acrylamido‐2‐methylpropanesulfonic acid‐co‐N‐isopropylacrylamide) semi‐interpenetrating network gels. J Appl Polym Sci 2007; 104: 1723–1731.

39.

Wong

Baji

Leng

Effect of fiber diameter on tensile properties of electrospun poly(ɛ-caprolactone). Polymer 2008; 49: 4713–4722.

40.

Gong

Guo

et al . Hyaluronan immobilized polyurethane as a blood contacting material. Int J Polym Sci 2010; 2010: 807935.

41.

Brash

Uniyal

Dependence of albumin–fibrinogen simple and competitive adsorption on surface properties of biomaterials. J Polym Sci C Polym Symp 1979; 66: 377–389.

42.

Salzman

Lindon

McManama

et al . Role of fibrinogen in activation of platelets by artificial surfaces. Ann N Y Acad Sci 1987; 516: 184–195.

43.

Martins

Wang

et al . Albumin and fibrinogen adsorption on PU–PHEMA surfaces. Biomaterials 2003; 24: 2067–2076.

44.

Kottke-Marchant

Anderson

Umemura

et al . Effect of albumin coating on the in vitro blood compatibility of Dacron® arterial prostheses. Biomaterials 1989; 10: 147–155.

45.

Tsai

Grunkemeier

McFarland

et al . Platelet adhesion to polystyrene‐based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand’s factor. J Biomed Mater Res 2002; 60: 348–359.

46.

Geer

Rus

Lord

et al . Surface-dependent fibrinopeptide A accessibility to thrombin. Acta Biomater 2007; 3: 63–68.

47.

Evans-Nguyen

Fuierer

Fitchett

Tolles

et al . Changes in adsorbed fibrinogen upon conversion to fibrin. Langmuir 2006; 22: 5115–5121.

48.

Moulin

Oshea

Badley

et al . Measuring surface-induced conformational changes in proteins. Langmuir 1999; 15: 8776–8779.

49.

Rabe

Verdes

Seeger

Understanding protein adsorption phenomena at solid surfaces. Adv Colloid Interface Sci 2011; 162: 87–106.

50.

Vroman

Adams

Fischer

et al . Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 1980; 55: 156–159.

51.

Andrade JD and Hlady V. Protein adsorption and materials biocompatibility: a tutorial review and suggested hypotheses. Advances in Polymer Science 1986; 79: 3–58.

52.

Andrade

Hlady

Vroman effects, techniques, and philosophies. J Biomater Sci Polym Ed 1991; 2: 161–172.

53.

Gorbet

Sefton

MV.

Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681–5703.

54.

Vogler

Siedlecki

CA.

Contact activation of blood-plasma coagulation. Biomaterials 2009; 30: 1857–1869.

55.

Davie

Fujikawa

Kisiel

The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363–10370.

56.

Pokhilko

Ataullakhanov

FI.

Contact activation of blood coagulation: trigger properties and hysteresis hypothesis: kinetic recognition of foreign surfaces upon contact activation of blood coagulation: a hypothesis. J Theor Biol 1998; 191: 213–219.